Quantcast

Latest Ketones Stories

2014-03-13 17:07:09

When initiated soon after menopause, hormone therapy with estradiol prevented degeneration in key brain regions of women who were at heightened dementia risk, according to a new study led by Stanford University School of Medicine researchers. The investigators also found that another type of hormone therapy, marketed under the brand name Premarin, was far less protective. Premarin is a mixture of 30-plus substances derived from the urine of pregnant mares. Estradiol — the dominant...

2014-03-13 08:28:57

WAYNE, Penn., March 13, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its fourth quarter and year ended December 31, 2013 financial results will be released on Wednesday, March 26, 2014. Following the announcement, Egalet's management will host a live conference call and webcast at 8:30 a.m. Eastern Time to review the company's financial and operating results and provide a general business update....

2014-03-12 23:28:06

Best Drug Rehabilitation, which offers addiction recovery geared to the personalized needs of each client, is focusing on the history of heroin in its latest blog post. (PRWEB) March 12, 2014 Best Drug Rehabilitation, which offers addiction recovery geared to the personalized needs of each client, is focusing on the history of heroin in its latest blog post. The history of heroin as we know it today dates back to 1895, when a German chemist attempted to change morphine chemically in...

2014-03-12 08:31:17

NEWARK, Calif., March 12, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that the U.S. Food and Drug Administration (FDA) approved Mallinckrodt plc's New Drug Application (NDA) for XARTEMIS(TM) XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), previously known as MNK-795, for the management of acute pain severe enough to require opioid treatment and in patients for whom alternative treatment options (e.g., non-opioid analgesics) are...

2014-03-12 08:30:24

Investigational Opioid Analgesic Incorporates Abuse-Deterrent Technology STAMFORD, Conn., March 12, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that a Phase 3 study of an investigational extended-release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once-daily analgesic agent experienced statistically significant reduction in pain compared with placebo (p=0.0016). This investigational...

2014-03-11 16:26:19

PITTSBURGH, March 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Naloxone Hydrochloride Injection USP, 0.4 mg/mL packaged in 1 mL single-dose vials. Mylan's product was determined to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Naloxone Hydrochloride Injection 0.4 mg/mL, of Hospira Inc. Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including...

2014-03-07 08:26:19

Two-thirds of states include methadone on preferred drug lists for Medicaid patients PHOENIX, March 7, 2014 /PRNewswire-USNewswire/ -- Two-thirds of states prefer methadone above other opioid medications to treat chronic pain, particularly in low-income residents, a practice top pain physicians say adds unnecessary risk. Physician leaders from the American Academy of Pain Medicine (AAPM) released a position paper today to warn all states and private insurers that methadone should...

2014-03-06 20:21:55

Researchers sought comprehensive predictors of opioid abuse in veterans based on discontinuation rates PHOENIX, March 6, 2014 /PRNewswire-USNewswire/ -- Of nearly 1 million veterans who receive opioids to treat painful conditions, more than half continue to consume opioids chronically or beyond 90 days, new research says. Results presented at the 30(th) Annual Meeting of the American Academy of Pain Medicine reported on a number of factors associated with opioid discontinuation with...

2014-03-05 23:30:09

Dr. Dominick Angiolillo begins clinical study of rapid CYP2C19 genotyping in Jacksonville. Ottawa, Ontario (PRWEB) March 05, 2014 Spartan Bioscience today announced the start of a study of personalized medicine at the University of Florida. The Spartan RX CYP2C19 System is being used to test heart attack patients receiving cardiac stents. The study is entitled “A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function...

2014-03-05 14:40:37

Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than 24,000 patients found a lower l-year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding, according to a study in the March 5 issue of JAMA. Juan Jesus Carrero, Ph.D., of the Karolinska Institutet, Stockholm, and colleagues...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related